a) fostering cross-fertilization of scientific knowledge among clinical and preclinical scientists as well as clinicians from relevant disciplines
b) defining and articulating clinical methods for the proper study and application of interventions to treat and prevent neuropsychiatric and brain disorders
c) developing consensus from scientific and medical data in order to recommend scientific and regulatory policies to improve the well-being and health of individuals with neuropsychiatric disorders in diverse and culturally distinct societies world-wide.
Executive Committee
CINP OFFICERS 2006-2008
President
Torgny H. Svensson M.D., Ph.D.
Karolinska Institutet
Dept. of Physiology and Pharmacology
Section for Neuropsychopharmacolgy
S-17177 Stockholm
Sweden
Tel: (46) (8) 52487921
Fax: (46) (8) 308424
Email: torgny.svensson@fyfa.ki.se
Secretary
Hans-Jürgen Möller M.D.
Psychiatrische Universitatsklinik
Nussbaumstrasse 7
D-80336 Munich
Germany
Tel: (49)(89) 5160 5501
Fax: (49)(89) 5160 5522
Email: hans-juergen.moeller@med.uni-muenchen.de
Treasurer
Lars Farde
Department of Clinical Neuroscience
Psychiatry Section
Karolinska Hosptal
SE-171
76 Stockholm
Sweden
Tel: (46) (8) 517 72673
Fax: (46) (8) 517 71753
Email: lars.farde@cns.ki.se
CINP EXECUTIVE COMMITTEE 2006-2008
President
Torgny Svensson
Past-President
Brian Leonard
President-Elect
Robert Belmaker
Vice-Presidents
Wolfgang Fleichhacker
Stephen Stahl
Secretary
Hans-Jürgen Möller
Treasurer
Lars Farde
Councillors
Pierre Blier
Eva Ceskova
Brian Dean
Johan Den Boer
Robin Emsley
Angelos Halaris
Tadafumi Kato
Donatella Marazziti
Nina Schooler
Alexandra Sulcova
Moussa Youdim
Executive Director for the CINP Central Office
Mike Mitchell
Biographical Scetch
Lars Farde, MD, PhD
Dr. Lars Farde has been Professor of Psychiatry at Karolinska Institutet since 1997 and is Chief Scientist in the CNS and Pain research area at AstraZeneca. Lars Farde graduated from medical school at the University of Umea in 1978 after which he moved to Stockholm for a residency in Psychiatry at the Karolinska Hospital. His PhD thesis on “Dopamine receptor characteristics in the living human brain” was presented in 1987. Dr. Farde’s research strategy is multidisciplinary and translational. He has contributed substantially to the development of Positron Emission Tomography as a methodology for quantitative imaging of brain neuroreceptors. The development includes original radioligands such as [11C]raclopride and [11C]SCH23390. The methods were subsequently used in clinical studies on the pathophysiology of schizophrenia. He was the first to demonstrate relationships between central dopamine receptor occupancy and clinical effects of antipsychotic drugs. This discovery initiated a series of pioneering studies on the use of brain imaging in drug development. He has more recently pioneered research on correlations between dopamine receptor number and human personality traits, an area which is or particular interest in relation to the anhedonia and social withdrawal that characterize several patients with schizophrenia. Dr. Farde has received five international awards.
Dr. Belmaker
Since 1974 Dr. Belmaker has held positions in academic psychiatry in Israel. He chaired the local committee of the CINP meeting in Jerusalem in 1982. Dr. Belmaker's 1976 paper in Nature on lithium and second messengers was one of the first in the field. In 1994 he received a NARSAD Distinguished Investigator Award on transcranial magnetic stimulation and has co-edited a book on TMS for psychiatrists. His 1996 paper in Nature Genetics on dopamine D-4 receptor polymorphisms and human personality was a landmark in the field.
He has received the Anna Monika Prize for Research in Depression (1983), the Ziskind-Somerfeld Prize for Senior Research in Biological Psychiatry (1993), the ECNP Lilly Research Award (1996), the NARSAD Falcone Award for research in affective disorder (2000) and the Research Prize of the World Federation of Societies of Biological Psychiatry (2004). Since 1998 he has been Associate Editor of Bipolar Disorders, and published a review of bipolar disorder in 2004 in the New England Journal of Medicine.
He served for 10 years as Chairman of his Department of Psychiatry and remains Associate Director of the Beersheva Mental Health Center. He sees patients every Monday in his public Mood Disorders Clinic and is actively involved in clinical trials as well as laboratory research.
